International Randomized Comparison Between DES Limus Carbostent and Taxus DES in the Treatment of De-novo Coronary Lesions

NCT01373502 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
323
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

CID - Carbostent & Implantable Devices